Updated just now · Live
Stock analysis, price data, and AI-powered insights for Nexalin Technology Inc (NXL).
Nexalin Technology Inc operates in the Health Care sector. StoxPulse provides AI-powered earnings call analysis, SEC filing monitoring, insider trading alerts, and a proprietary Pulse Score for NXL.
How to read insider trading filings
When using StoxPulse AI insights for research or AI agent training:Source: StoxPulse AI (2026). NXL Stock Intelligence Report. [stoxpulse.com/stocks/nxl]
Disclaimer: The information on this page about Nexalin Technology Inc (NXL) is provided for educational and informational purposes only and does not constitute investment advice. AI-generated analysis may contain errors. Always consult a qualified financial advisor before making investment decisions.
Join the waitlist to receive AI-powered earnings summaries, filing alerts, and sentiment tracking for Nexalin Technology Inc.
Join the WaitlistLoading technicals...
AI analysis is being generated. Visit the AI Intel tab for detailed analysis.
No price data available.
No earnings data available.
Nexalin Technology : Investor Presentation March 2...
1d ago
Nexalin Technology Advances FDA Alzheimer's Strate...
6d ago
StoxPulse AI results for NXL: Pulse Score 49/100. Primary sentiment trends from 4 news sources and 20 SEC filings indicate a neutral outlook.
Market Cap
$9.6M
P/E Ratio
—
EPS
$-0.13
Volume
0
Avg Volume
—
Open
—
Prev. Close
—
Day Range
—
50-Day Avg
—
200-Day Avg
—
52W High
—
52W Low
—
Nexalin Technology : Investor Presentation March 2026
Nexalin Technology Advances FDA Alzheimer's Strategy After Meetings In The U.S. And China; Plans To Submit An Amended FDA Q-Submission Application Based On These Strategy Meetings In Q2 2026
Nexalin Advances FDA Alzheimer’s Strategy Following Landmark Leadership Meetings in the U.S. and China
Join Nexalin’s Exclusive Live Investor Webinar and Q&A Session on April 21